论文部分内容阅读
目的观察肌氨肽苷注射剂治疗慢性心力衰竭(CHF)的疗效。方法将100例CHF患者随机分成肌氨肽苷治疗组和对照组,两组均应用强心、利尿、扩血管及神经内分泌阻滞剂并治疗原发病,治疗组在此基础上加用肌氨肽苷注射液。结果治疗组总有效率为96%,对照组总有效率为84%,肌氨肽苷治疗组疗效优于对照组,差异有统计学意义(P<0.05)。结论肌氨肽苷治疗慢性心力衰竭疗效显著,值得临床推广。
Objective To observe the efficacy of muscle aminopeptidase injection in the treatment of chronic heart failure (CHF). Methods One hundred patients with CHF were randomly divided into two groups: treatment with streptozotocin and control group. Cardiac, diuretic, vasodilator and neuroendocrine blockers were used to treat the primary disease in both groups. On the basis of this, Aminopeptidyl glycosides injection. Results The total effective rate was 96% in the treatment group and 84% in the control group, and the effect was better in the aminoglycoside treatment group than in the control group (P <0.05). Conclusion Muscle glycosides treatment of chronic heart failure significant effect, worthy of clinical promotion.